Brad Poore

1.2k total citations
14 papers, 208 citations indexed

About

Brad Poore is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Brad Poore has authored 14 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in Brad Poore's work include Glioma Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Mechanisms and Therapy (2 papers). Brad Poore is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Mechanisms and Therapy (2 papers). Brad Poore collaborates with scholars based in United States, China and Spain. Brad Poore's co-authors include Barbara S. Slusher, Jesse Alt, Eric H. Raabe, Charles G. Eberhart, AeRyon Kim, Tatiana Boronina, Marion Ciudad, Scheherazade Sadegh‐Nasseri, Robert N. Cole and Rachel R Caspi and has published in prestigious journals such as Nature Communications, Cancer Research and Clinical Cancer Research.

In The Last Decade

Brad Poore

13 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brad Poore United States	7	116	85	43	34	20	14	208
Denise Guerra Netherlands	4	167 1.4×	71 0.8×	14 0.3×	146 4.3×	15 0.8×	8	245
Antonio Palma United States	7	101 0.9×	73 0.9×	23 0.5×	8 0.2×	10 0.5×	21	219
Shahla Bari United States	8	81 0.7×	36 0.4×	32 0.7×	22 0.6×	7 0.3×	25	262
Subramanyam Chittivelu United States	6	138 1.2×	147 1.7×	20 0.5×	14 0.4×	6 0.3×	15	287
Nathan K. Leclair United States	8	444 3.8×	126 1.5×	32 0.7×	22 0.6×	19 0.9×	28	544
Jing-Yuan Chooi Singapore	9	277 2.4×	87 1.0×	41 1.0×	11 0.3×	6 0.3×	10	328
Mya Steadman United States	5	212 1.8×	122 1.4×	62 1.4×	26 0.8×	3 0.1×	7	334
Yoshihiro Sadamoto Japan	6	204 1.8×	158 1.9×	34 0.8×	5 0.1×	8 0.4×	10	340

Countries citing papers authored by Brad Poore

Since Specialization

Citations

This map shows the geographic impact of Brad Poore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Poore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Poore more than expected).

Fields of papers citing papers by Brad Poore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad Poore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Poore. The network helps show where Brad Poore may publish in the future.

Co-authorship network of co-authors of Brad Poore

This figure shows the co-authorship network connecting the top 25 collaborators of Brad Poore. A scholar is included among the top collaborators of Brad Poore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad Poore. Brad Poore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pham, Khoa, Allison R. Hanaford, Brad Poore, et al.. (2022). Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways. Cancers. 14(5). 1311–1311. 13 indexed citations

Poore, Brad, Allison R. Hanaford, Khoa Pham, et al.. (2021). TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. Cancer Letters. 504. 137–145. 5 indexed citations

Pham, Khoa, Brad Poore, Allison R. Hanaford, et al.. (2021). OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage. Neuro-Oncology Advances. 3(Supplement_2). ii15–ii15.

Poore, Brad, et al.. (2021). Retrospective Evaluation of the Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score. The Journal of Applied Laboratory Medicine. 7(1). 36–45. 1 indexed citations

Poore, Brad, et al.. (2021). A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays. Clinical Biochemistry. 95. 77–80. 10 indexed citations

Geno, K. Aaron, Brad Poore, Mark A Cervinski, & Robert D Nerenz. (2021). Gamma Glutamyl Transferase Activity Has Limited Utility in Assessment of Alkaline Phosphatase Elevations. The Journal of Applied Laboratory Medicine. 6(6). 1623–1627. 2 indexed citations

Zou, Han, Brad Poore, Alberto Broniscer, Ian F. Pollack, & Baoli Hu. (2020). Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma. Cancers. 12(3). 643–643. 17 indexed citations

Wang, Sabrina, Brad Poore, Jesse Alt, et al.. (2019). Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine. Clinical Cancer Research. 25(19). 5925–5936. 23 indexed citations

Hanaford, Allison R., Brad Poore, Jesse Alt, et al.. (2018). Abstract 3484: In vivo metabolomics reveals a potentially potent combination therapy for MYC-driven medulloblastoma. Cancer Research. 78(13_Supplement). 3484–3484. 3 indexed citations

10.

Poore, Brad, Ming Yuan, Antje Arnold, et al.. (2018). Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin. Neuro-Oncology. 21(2). 252–263. 22 indexed citations

11.

Poore, Brad & Antje Arnold. (2017). LGG-15. CARBOPLATIN IS SYNERGISTIC WITH MAPK INHIBITORS TRAMETINIB AND EVEROLIMUS IN LOW GRADE GLIOMA MODELS. Neuro-Oncology. 19(suppl_4). iv36–iv36. 1 indexed citations

12.

Zimmermann, Sarah C., Ajit G. Thomas, Marigo Stathis, et al.. (2016). Allosteric Glutaminase Inhibitors Based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane Scaffold. ACS Medicinal Chemistry Letters. 7(5). 520–524. 55 indexed citations

13.

Kim, AeRyon, Isamu Z. Hartman, Brad Poore, et al.. (2014). Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Nature Communications. 5(1). 5369–5369. 50 indexed citations

14.

Wang, Chunyu, Min Xue, Kourong Miao, et al.. (2005). Identification of an HLA‐B*07 allele variant (B*0740) in the Chinese Han population. Tissue Antigens. 66(2). 148–150. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact